HealthEquity Net Income Applicable To Common Shares from 2010 to 2025

HQY Stock  USD 110.57  1.77  1.63%   
HealthEquity Net Loss yearly trend continues to be fairly stable with very little volatility. Net Loss is likely to outpace its year average in 2025. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2012-04-30
Previous Quarter
4.1 M
Current Value
10.6 M
Quarterly Volatility
13 M
 
Yuan Drop
 
Covid
Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 184.8 M, Interest Expense of 67 M or Selling General Administrative of 125.2 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0735 or PTB Ratio of 5.64. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.
  
Check out the analysis of HealthEquity Correlation against competitors.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Latest HealthEquity's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of HealthEquity over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. HealthEquity's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HealthEquity's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

HealthEquity Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean7,318,127
Coefficient Of Variation422.99
Mean Deviation23,141,466
Median11,169,000
Standard Deviation30,954,920
Sample Variance958.2T
Range118.2M
R-Value(0.45)
Mean Square Error821.2T
R-Squared0.20
Significance0.08
Slope(2,908,277)
Total Sum of Squares14373.1T

HealthEquity Net Income Applicable To Common Shares History

2025-22.4 M
2024-23.5 M
2022-26.1 M
2021-44.3 M
20208.8 M
201939.7 M
201873.9 M

About HealthEquity Financial Statements

HealthEquity investors use historical fundamental indicators, such as HealthEquity's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-23.5 M-22.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.